is wegovy a glp-1 drug weight loss drugs may be misused by patients with eating disorders: Study America's Weight-Loss Drug Boom Is
Description
The phase 2 study to evaluate the efficacy, safety and tolerability of maridebart cafraglutide is currently ongoing (ClinicalTrials.gov number, NCT05669599)
doi: 10.1016/j.cub.2024.02.074
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
The next generation of oral GLP-1 agents like orforglipron may also offer different receptor binding kinetics that reduce desensitization risk

A few other nuggets: Exenatide may cross the blood-brain barrier more effectively than lixisenatide

This proactive assessment helps identify potential risks early
